Navigation Links
BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
Date:10/27/2008

Management to Host Conference Call at 8:30 a.m. Eastern Time Today to

Discuss Results

BIRMINGHAM, Ala., Oct. 27 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced results of an exploratory Phase 2 trial of intravenous (i.v.) peramivir, a neuraminidase inhibitor, in patients hospitalized for acute serious or potentially life-threatening influenza. The Phase 2 trial compared the efficacy and safety of five days of therapy with either 200 mg i.v. peramivir per day, 400 mg i.v. peramivir per day or 75 mg oral oseltamivir twice a day, in patients who required hospitalization related to influenza. These results will be submitted to an upcoming medical meeting.

The primary objective of the study was to evaluate time to clinical stability, which is a composite endpoint comprised of normalization of temperature, oxygen saturation, respiratory rate, systolic blood pressure and heart rate. This type of endpoint has previously been used in pneumonia studies, but not in influenza. Secondary objectives of the study included evaluation of viral shedding, mortality, clinical relapse and time to resumption of usual activities.

In the primary efficacy population, for all groups combined, the study demonstrated a median of 25.3 hours to clinical stability, a median of 2.0 log reduction in time weighted change from baseline in viral titer, zero mortality, no clinical relapse and a median of 10.8 days of time to resumption of usual activities. There were no statistically significant differences in any of the efficacy endpoints between the three treatment arms. Peramivir was generally safe and well-tolerated at these dose levels.

"This landmark study provides us gre
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
7. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
8. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. BioCryst to Present at UBS 2008 Global Life Sciences Conference
11. BioCryst to Present at the JMP Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... (PRWEB) April 01, 2015 Shimadzu ... chromatography-based Nexera Unified Chromatography system (Nexera UC) received ... Pittsburg Conference on Analytical Chemistry and Applied Spectroscopy ... 8th and 12th. , The Pittcon Editors’ ... Pittcon for the first time based on votes ...
(Date:4/1/2015)... , April 1, 2015  ValGenesis Inc., the ... announced today that it has completed its Service Organization ... Attest Engagements (AICPA, Professional Standards) for the period of ... 2014.  ... The SOC 2 ...
(Date:4/1/2015)... IRVINE, CA (PRWEB) April 01, 2015 ... in Personalized Medicine , presented two scientific posters ... City, Utah, last week. The four-day event was hosted ... 2,000 genetic specialists dedicated to educating genetic and genomic ... Biosciences presented Genetics and Insomnia: Study on the Role ...
(Date:4/1/2015)... DIEGO , April 1, 2015  Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... three-dimensional kidney tissue at the 2015 Experimental Biology ... "Kidney represents an ideal extension ... that can be tremendously useful in pharmaceutical research," ...
Breaking Biology Technology:Shimadzu Nexera UC Recognized at Pittcon 2015 with Editors’ Gold Award 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4
... Guidance of $350 million to $360 million, WARSAW, ... ), an independent provider of products to the global ... quarter 2007 revenue of $79.1 million. The Company stated ... time., As previously announced on October 4, 2007, ...
... Sanofi-aventis announced,today that the Chicago Athenaeum Museum of ... Award for the new SoloSTAR(R) disposable,insulin injection pen ... diabetes., "LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the ... been designed in dialogue with,patients, nurses and doctors ...
... researchers at the Georgia Institute of Technology are developing ... motion and converts it into electricity for powering small ... and other users. , The research, funded by ... Feb. 14 issue of Nature, details how pairs of ...
Cached Biology Technology:Symmetry Medical Reports Preliminary Fourth Quarter Revenue 2Symmetry Medical Reports Preliminary Fourth Quarter Revenue 3Symmetry Medical Reports Preliminary Fourth Quarter Revenue 4Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 2Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 3Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 4Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 5Remarkable new clothing may someday power your iPod 2
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
(Date:3/23/2015)... OXFORD, Conn. , Mar. 23, 2015 NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, announces ... a new advertising campaign on CNBC television starting March 30 ... ads will commence airing in New York ... Executive Officer said: "We are excited about our new ad ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... a genetic cause of a mysterious neurological disease in ... illness, Primary Progressive Aphasia, differs from Alzheimer's Disease in ... a little known form of dementia, people lose the ... , "This discovery, for the first time, provides a ...
... often cause dramatic symptoms such as the formation of ... fungi can even make infected plants smell like rotting ... farmers who are counting on their crops, such as ... , Natural Sciences and Engineering Research Council (NSERC) ...
... Natural Sciences and Engineering Research Council grantee Robert Reisz discovering ... that stands on two legs. , Now, he is ... by joining the ranks of the American Association for the ... a fellow during its annual conference, being held from Feb. ...
Cached Biology News:Researchers discover genetic cause for word-finding disease 2Stopping plants from getting sick 2Old dinosaur research leads to new honor 2